Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.22%390.29M | -4.11%711.16M | -9.08%378.09M | 8.88%741.62M | 32.86%415.84M | 14.36%681.16M | 17.49%312.98M | 7.19%595.62M | 9.11%266.4M | -4.21%555.66M |
| Operating income | 3.22%390.29M | -4.11%711.16M | -9.08%378.09M | 8.88%741.62M | 32.86%415.84M | 14.36%681.16M | 17.49%312.98M | 7.19%595.62M | 9.11%266.4M | -4.21%555.66M |
| Cost of sales | 1.68%-234.56M | 2.45%-445.02M | 4.95%-238.56M | -5.09%-456.18M | -20.06%-250.99M | -23.12%-434.09M | -33.66%-209.05M | -12.91%-352.57M | -11.24%-156.41M | 2.78%-312.27M |
| Operating expenses | 1.68%-234.56M | 2.45%-445.02M | 4.95%-238.56M | -5.09%-456.18M | -20.06%-250.99M | -23.12%-434.09M | -33.66%-209.05M | -12.91%-352.57M | -11.24%-156.41M | 2.78%-312.27M |
| Gross profit | 11.61%155.73M | -6.76%266.13M | -15.35%139.53M | 15.53%285.44M | 58.61%164.84M | 1.66%247.08M | -5.51%103.93M | -0.14%243.04M | 6.23%109.99M | -5.97%243.39M |
| Selling expenses | -2.33%-86.55M | -1.24%-175.26M | -1.45%-84.58M | -8.31%-173.12M | -11.91%-83.37M | 2.95%-159.84M | 5.43%-74.5M | 2.70%-164.69M | -4.76%-78.78M | 10.99%-169.27M |
| Administrative expenses | 10.57%-35.75M | 0.58%-76.75M | -0.74%-39.97M | 2.72%-77.2M | -0.97%-39.68M | -7.71%-79.36M | -5.44%-39.3M | 18.50%-73.68M | 2.89%-37.27M | -12.82%-90.4M |
| Impairment and provision | ---- | ---90M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---90M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 3.41%28.32M | 72.42%54.59M | 147.13%27.39M | 12.32%31.66M | -24.48%11.08M | 49.32%28.19M | 71.34%14.68M | -39.48%18.88M | -28.93%8.57M | 62.25%31.19M |
| Operating profit | 45.74%61.75M | -131.88%-21.29M | -19.88%42.37M | 85.14%66.78M | 999.13%52.88M | 53.16%36.07M | 91.75%4.81M | 57.86%23.55M | 24.58%2.51M | 91.58%14.92M |
| Financing cost | 19.91%-185K | -6.49%-361K | 0.43%-231K | 68.47%-339K | 52.07%-232K | 30.24%-1.08M | 55.60%-484K | 35.06%-1.54M | 23.02%-1.09M | 47.01%-2.37M |
| Earning before tax | 46.10%61.56M | -132.59%-21.65M | -19.96%42.14M | 89.85%66.45M | 1,116.71%52.65M | 59.00%35M | 204.93%4.33M | 75.43%22.01M | 137.29%1.42M | 279.06%12.55M |
| Tax | -188.73%-10.48M | -88.17%2.74M | -88.76%-3.63M | 1,341.81%23.14M | ---1.92M | -2,020.62%-1.86M | ---- | -92.56%97K | ---- | -73.87%1.3M |
| After-tax profit from continuing operations | 32.66%51.09M | -121.12%-18.92M | -24.08%38.51M | 170.35%89.58M | 1,072.29%50.73M | 49.88%33.14M | 204.93%4.33M | 59.61%22.11M | 137.29%1.42M | 66.88%13.85M |
| Earning after tax | 32.66%51.09M | -121.12%-18.92M | -24.08%38.51M | 170.35%89.58M | 1,072.29%50.73M | 49.88%33.14M | 204.93%4.33M | 59.61%22.11M | 137.29%1.42M | 66.88%13.85M |
| Minority profit | 62.00%1.45M | -67.93%1.18M | -59.58%892K | 343.61%3.68M | 1,383.14%2.21M | -69.75%830K | -162.09%-172K | 181.26%2.74M | 112.67%277K | -2.86%-3.38M |
| Profit attributable to shareholders | 31.97%49.64M | -123.40%-20.1M | -22.47%37.62M | 165.90%85.9M | 978.42%48.52M | 66.83%32.31M | 293.96%4.5M | 12.40%19.36M | -58.99%1.14M | 48.74%17.23M |
| Basic earnings per share | 31.68%0.133 | -121.74%-0.05 | -22.31%0.101 | 155.56%0.23 | 983.33%0.13 | 80.00%0.09 | 300.00%0.012 | 0.00%0.05 | -62.50%0.003 | 66.67%0.05 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | KPMG | -- | PwC accounting firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.